Physician
El-Masry, Sherif
El-Masry, Sherif was paid $448K by Medicaid between Jan 2018 and Nov 2024, across 25 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 46% of everything it billed.
33Billing provider infoEL-MASRY, SHERIF
YONKERS, NY 10701
YONKERS, NY 10701
33aNPI1588611685assigned 05/27/2006
33bProvider typeUrology Physician
28Total paid$448K
24GClaims29,510
24DCodes billed25
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Urology Physician providers in New York
Rank by total paid#35 of 461
Median peer was paid$6K
This provider vs. median78×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,696 | $29K | |
| 2019 | 4,568 | $47K | |
| 2020 | 4,214 | $58K | |
| 2021 | 5,576 | $89K | |
| 2022 | 5,191 | $96K | |
| 2023 | 4,264 | $89K | |
| 2024incomplete | 2,001 | $41K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 46% | 7,567 | 7,249 | $205K |
| 52000 | 14% | 1,060 | 1,058 | $65K | |
| 76872 | 9.6% | 994 | 984 | $43K | |
| 76775 | 7.1% | 1,462 | 1,456 | $32K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.7% | 670 | 663 | $25K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 5.1% | 340 | 340 | $23K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 4.0% | 225 | 225 | $18K |
| 51741 | 2.8% | 2,726 | 2,636 | $12K | |
| 51798 | 1.6% | 3,302 | 3,164 | $7K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.0% | 1,283 | 1,229 | $5K |
| 81002 | <1% | 5,239 | 5,042 | $3K | |
| 52281 | <1% | 29 | 28 | $3K |
13 more codes
| 96402 | <1% | 365 | $3K | |
| J1071 | Injection, testosterone cypionate, 1 mg | <1% | 723 | $2K |
| 93980 | <1% | 51 | $1K | |
| 51729 | <1% | 12 | $760.44 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,232 | $511.32 |
| 51797 | <1% | 12 | $310.96 | |
| 51784 | <1% | 12 | $88.70 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 30 | $20.50 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 66 | $0.99 |
| J2440 | Injection, papaverine hcl, up to 60 mg | 0% | 24 | $0.00 |
| J0270 | Injection, alprostadil, 1.25 mcg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 0% | 24 | $0.00 |
| 54235 | 0% | 37 | $0.00 | |
| J2760 | Injection, phentolamine mesylate, up to 5 mg | 0% | 25 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.